Manila Times Business
Aerska Strengthens Board with Appointments of Uli Stilz and Itziar Canamasas
DUBLIN and LONDON, 15 June 2026 -- Aerska, a biotechnology company using brain shuttle technology to develop RNA medicines for CNS diseases, today announces the appointment of Itziar Canamasas and Uli Stilz to the Company’s Board of Directors. These senior appointments bring decades of expertise in drug development to Aerska. Itziar, currently Global Head of Oncology at Boehringer Ingelheim, brings more than two decades of strategic and commercial leadership in precision medicine. She will help
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Twenty-six years later: Finally seeing the first sunrise at Pusan Point
Just now
BSB Junrose strengthens portfolio for hybrid, EV, and conventional vehicles
Just now
FAW trucks launches 'Wheels of Hope' outreach for Rizal school
Just now
100x Leverage, No KYC, $50 Welcome Bonus, and Double Deposit Bonus - Trade Crypto Futures on BexBack
Just now